Monsanto Company (MON) - NYSE
  • Wed, Apr. 6, 8:58 AM
    • Monsanto (NYSE:MON) -1.6% premarket after reporting weaker than expected FQ2 earnings and revenues, hurt by steep discounting on its seeds and a stronger dollar.
    • MON says revenue from seeds and genomics, its biggest business, fell 8.6% Y/Y in the quarter as sales of most seed types fell, while revenues in its agricultural productivity segment tumbled 30% to $715M; total sales fell 12.8% to $4.53B from $5.2B a year earlier.
    • MON reiterates its full-year EPS forecast of $4.40-$5.10, which was lowered last month from a prior outlook for $5.10-$5.60.
    • MON says it continues to expect relatively flat Y/Y growth in gross profit from its core seeds and genomics segment in FY 2016; excluding currency headwinds of nearly $400M, MON estimates seeds and genomics gross profit to rise by single digits, driven primarily by the expected increase in potential licensing deals, increased Intacta RR2 PRO soybean adoption and global corn market expansion.
    • Now read Monsanto's Plan B: Buy Bayer Cropscience?
    | Wed, Apr. 6, 8:58 AM
  • Wed, Apr. 6, 8:04 AM
    • Monsanto (NYSE:MON): FQ2 EPS of $2.42 misses by $0.02.
    • Revenue of $4.5B (-13.5% Y/Y) misses by $260M.
    • Press Release
    | Wed, Apr. 6, 8:04 AM
  • Tue, Apr. 5, 5:30 PM
  • Wed, Jan. 6, 9:11 AM
    • Monsanto (NYSE:MON-2.3% premarket after reporting better than expected Q1 earnings but disappointing revenues as corn sales weakened in Latin America.
    • MON lowers its FY 2016 EPS guidance to the lower half of its prior guidance range of $5.10-$5.60, vs. $5.27 analyst consensus estimate, partly due to the recent devaluation of the Argentine peso.
    • MON also raises the number of jobs it expects to cut as part of a restructuring plan to 3,600, or 16% of the global workforce, from 2,600 announced in October; the latest cuts will result in $1.1B-$1.2B in restructuring charges, more than previously expected charges of $850M-$900M.
    • MON says Q4 soybean sales rose 11% Y/Y to $438M, as U.S. farmers have dedicated more fields to soybeans in pursuit of higher profits; sales in the ag productivity segment, which includes Roundup brand weed killer, fell to $820M from $1.25B a year earlier.
    | Wed, Jan. 6, 9:11 AM
  • Wed, Jan. 6, 8:03 AM
    • Monsanto (NYSE:MON): FQ1 EPS of -$0.11 beats by $0.11.
    • Revenue of $2.22B (-22.6% Y/Y) misses by $190M.
    • Press Release
    | Wed, Jan. 6, 8:03 AM
  • Tue, Jan. 5, 5:30 PM
  • Oct. 7, 2015, 9:17 AM
    • Monsanto (NYSE:MON) -4.6% premarket after reporting FQ4 earnings and revenues that missed expectations, as corn seed sales continue to weaken.
    • MON says it plans to cut 2,600 employees over the next two years, ~12% of its global workforce, with the aim of generating $275M-$300M in annual savings.
    • MON also plans some restructuring actions costing an estimated $850M-$900M, and announces a new $3B stock buyback program.
    • MON forecasts FY 2016 EPS of $5.10-$5.60 vs. $6.24 analyst consensus estimate; "it’s hard to see where growth will come from next year. The seed environment doesn’t seem entirely robust here or in South America,” says Monness Crespi analyst Chris Shaw.
    • Says FY 2015 results reflected Y/Y ongoing EPS growth of 10%, or ~17% on an ongoing currency neutral basis, despite the downturn in the agriculture cycle.
    • For FQ4, MON says corn sales, its biggest source of profit, fell 5.1% Y/Y to $598M, and soybean sales dropped 19% to $162M; sales in the agricultural productivity segment, which includes the Roundup brand weed killer, fell to $1.1B from $1.25B.
    • FQ4 gross margin fell to 42% from 47%.
    | Oct. 7, 2015, 9:17 AM
  • Oct. 7, 2015, 8:54 AM
    • Monsanto (NYSE:MON): FQ4 EPS of -$0.19 misses by $0.17.
    • Revenue of $2.36B (-10.3% Y/Y) misses by $400M.
    | Oct. 7, 2015, 8:54 AM
  • Oct. 6, 2015, 5:30 PM
  • Jun. 24, 2015, 8:55 AM
    • Monsanto (NYSE:MON) +0.2% premarket after reporting FQ3 earnings that easily beat estimates and sales that rose 8% Y/Y to nearly $4.6B, but it also expects FQ4 earnings to break even while analyst consensus had forecast EPS of ~$0.33.
    • MON reaffirms guidance for the full year, expecting EPS at the low end of $5.75-$6.00 vs. $5.77 analyst consensus; gross profit growth percentage in the Seeds and Genomics segment is now seen flat Y/Y, while Ag Productivity gross profit is now seen down only slightly due to the agreement with Scotts Miracle Gro as an offset to the anticipated 15%-17% decline in gross profit from continued softening of generic glyphosate pricing and currency headwinds.
    • For the current quarter, corn seed and traits sales of $1.52B were slightly below expectations, while ag productivity sales of $1.39B slightly beat consensus.
    • MON says it plans to spend more than $1B over the next three to five years for production of dicamba weedkiller at its plant in Luling, La.; it expects to begin selling crop seeds genetically engineered to tolerate both Roundup and dicamba next year to help farmers control weeds no longer killed by Roundup alone.
    | Jun. 24, 2015, 8:55 AM
  • Jun. 24, 2015, 8:02 AM
    • Monsanto (NYSE:MON): FQ3 EPS of $2.39 beats by $0.32.
    • Revenue of $4.58B (+7.8% Y/Y) misses by $30M.
    | Jun. 24, 2015, 8:02 AM
  • Jun. 23, 2015, 5:30 PM
    | Jun. 23, 2015, 5:30 PM | 1 Comment
  • Apr. 1, 2015, 8:52 AM
    • Monsanto (NYSE:MON) -0.6% premarket after missing expectations for FQ2 earnings and revenues on weakness in both its seeds and genomics and agricultural productivity businesses.
    • MON says current guidance for FY 2015 EPS is trending at the lower end of its previously forecast $5.75-$6.00 range and below the $5.84 analyst consensus estimate, as a strengthening U.S. dollar erodes sales abroad; MON says the negative effect of currency moves would reduce EPS by $0.35-$0.40.
    • FQ2 corn seed and trait sales fell 15% Y/Y to $2.91B, but MON says it remains on track to hold or grow its branded corn-share footprint in every major market despite the decline in acres of corn being planted.
    • Soybean seed and traits sales rose 7.7% to $883M; sales in the agricultural productivity business, which consists of crop-protection products and herbicides, fell 14% to $1.02B.
    | Apr. 1, 2015, 8:52 AM | 6 Comments
  • Apr. 1, 2015, 8:04 AM
    • Monsanto (NYSE:MON): FQ2 EPS of $2.90 misses by $0.03.
    • Revenue of $5.2B (-10.8% Y/Y) misses by $380M.
    | Apr. 1, 2015, 8:04 AM
  • Mar. 31, 2015, 5:30 PM
Company Description
Monsanto Co. engages in the distribution of agricultural products to farmers. The company operates its business through the following business segments: Seeds & Genomics and Agricultural Productivity. The Seeds & Genomics segment produces seed brands, including DEKALB, Asgrow, Deltapine,... More
Industry: Agricultural Chemicals
Country: United States